| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 06/12/2002 | EP1032571B1 Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance p antagonists |
| 06/12/2002 | EP1023263B1 Novel vitamin d analogues |
| 06/12/2002 | EP0941056B1 Sphingomyelinase compositions and use thereof |
| 06/12/2002 | EP0928193B1 Use of 1-hydroxy-2-pyridones for the treatment of skin diseases |
| 06/12/2002 | EP0888327B1 Benzopyran derivatives having leukotriene-antagonistic action |
| 06/12/2002 | EP0885204B1 Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds |
| 06/12/2002 | EP0880533B1 Triazole derivatives useful in therapy |
| 06/12/2002 | EP0873362B1 PROCESS FOR ISOLATING IgG AND IgA |
| 06/12/2002 | EP0751778B1 Use of deuterium-depleted water for preparing hygienic and cosmetic preparations |
| 06/12/2002 | EP0737200B1 Biologically active silicon compounds and their therapeutic and cosmetic applications |
| 06/12/2002 | EP0689427B1 Water dispersible therapeutic carotenoid compounds |
| 06/12/2002 | EP0688211B1 Thalidomide for inhibition of angiogenesis |
| 06/12/2002 | CN1353754A Variants of TRAF2 which act as an inhibitor of TNF-alpha (TNF alpha) signaling pathway |
| 06/12/2002 | CN1353735A Silicone gel containing salicylic acid |
| 06/12/2002 | CN1353709A Bicyclic oxazolidinones as antibacterial agents |
| 06/12/2002 | CN1353706A Integrin receptor ligands |
| 06/12/2002 | CN1353701A Peptidyl heterocyclic ketones useful as tryptase inhibitors |
| 06/12/2002 | CN1353699A Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents |
| 06/12/2002 | CN1353698A Novel morpholine derivatives, method for production thereof and pharmaceutical preparations containing said derivatives |
| 06/12/2002 | CN1353697A 4-phenyl-pyrimidine derivatives |
| 06/12/2002 | CN1353696A 5-phenyl-pyrimidine derivatives |
| 06/12/2002 | CN1353690A Bradykinin receptor antagonists |
| 06/12/2002 | CN1353688A Compounds derived from benzoic acid esters, composition comtaining said compounds and use thereof |
| 06/12/2002 | CN1353611A Balsam for treatment of surface burns and chafing rashes |
| 06/12/2002 | CN1353609A Amide substituted imidazoquinolines |
| 06/12/2002 | CN1353606A IL-8 receptor antagonists |
| 06/12/2002 | CN1352978A Medicine 'Shenfeishu' for treating nephrosis and lung disease and its preparing process |
| 06/12/2002 | CN1352975A Composite medicine for treating acne and spots and its preparing process |
| 06/12/2002 | CN1352971A Eczema tablet |
| 06/12/2002 | CN1352969A Universal surgical plaster |
| 06/12/2002 | CN1352952A Prescription of Pugonglian Herbal medicine |
| 06/12/2002 | CN1352950A Liquid medicine for treating wound and sore and its preparing process |
| 06/12/2002 | CN1352947A Mamma-repairing chitin liquid |
| 06/12/2002 | CN1352930A Medicine 'pearl powder' for treating smelly foot, hircus and dermatopathy |
| 06/12/2002 | CN1086140C Medicine for treating tinea and its preparing process |
| 06/12/2002 | CN1086136C External application ointment for curing burn |
| 06/12/2002 | CN1086135C Oily medicine for treating burns |
| 06/12/2002 | CN1086130C Chinese medicine composition for treating scabies, and method for preparing same |
| 06/12/2002 | CN1086125C Externally used medicine for treating tinea |
| 06/11/2002 | US6404779 System and method of disharmonic frequency multiplexing |
| 06/11/2002 | US6403830 Amidino compound and salts thereof useful as nitric oxide synthase inhibitors |
| 06/11/2002 | US6403805 1,3-dihydro-1-(phenylalkyl)-2H-imidazol-2-one derivatves |
| 06/11/2002 | US6403791 Treatment of inflammatory diseases or autoimmune diseases in humans or animals |
| 06/11/2002 | US6403656 Skin disorders |
| 06/11/2002 | US6403638 2,4-pentadienoic acid derivatives having selective activity for retinoid X (RXR) receptors |
| 06/11/2002 | US6403619 Method for controlling cell necrosis or apoptosis |
| 06/11/2002 | US6403618 Administering picolinic acid derivatives to chelate with zinc and iron in proteins; antiangiogenic and antineoplastic agent |
| 06/11/2002 | US6403616 Chemical process and pharmaceutical formulation |
| 06/11/2002 | US6403611 Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions |
| 06/11/2002 | US6403604 Nitrogen-based camptothecin derivatives |
| 06/11/2002 | US6403587 Autoimmune diseases, acute and chronic inflammatory conditions, allergic conditions, infection associated with inflammation, viral, transplantation tissue rejection, atherosclerosis, restenosis, hiv infectivity, and |
| 06/11/2002 | US6403577 Hexamethyleneiminyl tachykinin receptor antagonists |
| 06/11/2002 | US6403570 Method of curing an injury to a skin surface |
| 06/11/2002 | US6403565 Enhances dna repair and prevents consequences of mutagenic radiation even when administered after damage or exposure to radiation has already occurred; deoxyribonucleosides: deoxycytidine, deoxyadenosine, deoxyguanosine, and thymidine. |
| 06/11/2002 | US6403349 Elongation of polyunsaturated fatty acid such as linolenic acid to dihomogamma linolenic acid; nucleotide sequence encodes polypeptide; genetic engineering; animal feeds, nutrients, cosmetics |
| 06/11/2002 | US6403112 Ectoin and ectoin derivatives as moisturizers in cosmetics |
| 06/11/2002 | US6403110 Topical treatment for oily skin |
| 06/11/2002 | US6403091 Produced by the hybridoma having atcc accession no. hb 10916. |
| 06/11/2002 | US6403087 Soluble lymphotoxin-β receptors as therapeutic agents for the treatment of immunological disease |
| 06/11/2002 | CA2240777C Triazole derivatives useful in therapy |
| 06/11/2002 | CA2198578C Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions |
| 06/11/2002 | CA2074050C Diclofenac sodium plaster |
| 06/06/2002 | WO2002044393A1 Recombinant viral and non-viral vectors containing the human urokinase plasminogen activator gene and its utilization in the treatment of various types of hepatic, renal, pulmonary, pancreatic and cardiac fibrosis and hypertrophic scars |
| 06/06/2002 | WO2002044379A2 Transforming growth factor-beta-related molecules and uses thereof |
| 06/06/2002 | WO2002044320A2 Human elongase genes and uses thereof |
| 06/06/2002 | WO2002044271A2 Surfactant-containing cosmetic, dermatological and pharmaceutical agents |
| 06/06/2002 | WO2002044187A2 Cyclic salen-metal compounds as scavengers for oxygen radicals and useful as antioxidants in the treatment and prevention of diseases |
| 06/06/2002 | WO2002044176A1 3-substituted quinuclidines and their use as nicotinic agonists |
| 06/06/2002 | WO2002044168A2 Indole-type inhibitors of p38 kinase |
| 06/06/2002 | WO2002044165A1 Quinoline derivatives as nk-3 antagonists |
| 06/06/2002 | WO2002044158A1 Salts of a isothiazole-4-carboxamide and their use as anti-hyperproliferation agents |
| 06/06/2002 | WO2002044154A1 Novel compounds |
| 06/06/2002 | WO2002044153A1 4-6-diphenyl pyridine derivatives as antiinflammatory agents |
| 06/06/2002 | WO2002044139A1 Cyclohexyl(alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same |
| 06/06/2002 | WO2002044120A1 Compounds active at the glucocorticoid receptor iii |
| 06/06/2002 | WO2002043774A2 Compositions and therapeutical use of polynucleotides encoding tcrs |
| 06/06/2002 | WO2002043766A1 Medicinal compositions and process for producing the same |
| 06/06/2002 | WO2002043762A2 Combination of gaba agonists and sorbitol dehydrogenase inhibitors |
| 06/06/2002 | WO2002043758A2 Uses of mammalian genes and related reagents |
| 06/06/2002 | WO2002043755A1 Use of bromelain for the treatment of inflammatory diseases and for adjuvant therapy during wound healing processes |
| 06/06/2002 | WO2002043751A1 Use of insulin containing composition for wound treatment |
| 06/06/2002 | WO2002043745A2 Histaminase of vegetable origin for use in the treatment of allergic and septic shock and of allergic asthma |
| 06/06/2002 | WO2002043739A2 Dermatological formulations containing clindamycin and a zinc-salt |
| 06/06/2002 | WO2002043736A1 Beautifying foods and drinks and peroral beautifying preparations |
| 06/06/2002 | WO2002043734A1 Novel compounds |
| 06/06/2002 | WO2002043731A2 Treatments for neurogenetic disorders, impulse control disorders, and wound healing |
| 06/06/2002 | WO2002043728A1 Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| 06/06/2002 | WO2002043691A1 Skin cream stimulating the surface bloodstream |
| 06/06/2002 | WO2002043689A2 Cosmetic, pharmaceutical and dermatological products |
| 06/06/2002 | WO2002043686A2 Acid cosmetic, dermatological and pharmaceutical agents |
| 06/06/2002 | WO2002043652A2 Anti-proliferative drugs |
| 06/06/2002 | WO2002043648A2 Compounds active at the glucocorticoid receptor ii |
| 06/06/2002 | WO2002020474A3 Resorcinol derivatives |
| 06/06/2002 | WO2002015866A3 USE OF CYCLIC 2,4-DIPHOSPHOGLYCERATES (cDGP) AND/OR DERIVATIVES THEREOF IN COSMETIC AND DERMATOLOGICAL FORMULATIONS |
| 06/06/2002 | WO2002012242A3 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 06/06/2002 | WO2002007683B1 Antimicotic nail varnish composition |
| 06/06/2002 | WO2002002072A3 Skin care cosmetic compositions containing phosphates and/or sulfates of branched alcohols and/or ethoxylates thereof |
| 06/06/2002 | WO2001094293A3 Benzamide ligands for the thyroid receptor |
| 06/06/2002 | WO2001091696A3 Use of biguanide derivatives for making a medicine having a wound healing effect |
| 06/06/2002 | WO2001090334A3 Drug metabolizing enzymes |